Compare, Analyse JUBILANT LIFE SCIENCES with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   MYLAN
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
MYLAN
Dec-18
JUBILANT LIFE SCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs8983,377-   
Low Rs6181,859-   
Sales per share (Unadj.) Rs572.01,554.0-  
Earnings per share (Unadj.) Rs36.242.2-  
Cash flow per share (Unadj.) Rs59.5333.2-  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs301.91,681.1-  
Shares outstanding (eoy) m159.28514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.7 78.6%   
Avg P/E ratio x20.962.0 33.7%  
P/CF ratio (eoy) x12.77.9 162.0%  
Price / Book Value ratio x2.51.6 161.2%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m120,6941,346,989 9.0%   
No. of employees `0002.435.0 6.8%   
Total wages/salary Rs m19,2600-   
Avg. sales/employee Rs Th38,120.622,843.9 166.9%   
Avg. wages/employee Rs Th8,058.40-   
Avg. net profit/employee Rs Th2,414.3620.3 389.2%   
INCOME DATA
Net Sales Rs m91,108799,536 11.4%  
Other income Rs m3570-   
Total revenues Rs m91,466799,536 11.4%   
Gross profit Rs m17,390206,890 8.4%  
Depreciation Rs m3,709149,705 2.5%   
Interest Rs m2,19838,455 5.7%   
Profit before tax Rs m11,84018,731 63.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,268-2,980 -109.7%   
Profit after tax Rs m5,77021,711 26.6%  
Gross profit margin %19.125.9 73.8%  
Effective tax rate %27.6-15.9 -173.5%   
Net profit margin %6.32.7 233.2%  
BALANCE SHEET DATA
Current assets Rs m45,848446,460 10.3%   
Current liabilities Rs m20,897325,519 6.4%   
Net working cap to sales %27.415.1 181.0%  
Current ratio x2.21.4 160.0%  
Inventory Days Days5784 68.0%  
Debtors Days Days5193 54.6%  
Net fixed assets Rs m65,498155,097 42.2%   
Share capital Rs m159426 37.4%   
"Free" reserves Rs m47,9300-   
Net worth Rs m48,089864,951 5.6%   
Long term debt Rs m42,429933,560 4.5%   
Total assets Rs m114,6852,320,136 4.9%  
Interest coverage x6.41.5 429.5%   
Debt to equity ratio x0.91.1 81.7%  
Sales to assets ratio x0.80.3 230.5%   
Return on assets %6.92.6 267.9%  
Return on equity %12.02.5 478.0%  
Return on capital %12.43.2 390.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,8050-   
CASH FLOW
From Operations Rs m11,215166,144 6.8%  
From Investments Rs m-10,118-85,878 11.8%  
From Financial Activity Rs m6,574-77,399 -8.5%  
Net Cashflow Rs m7,6121,376 553.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare JUBILANT LIFE SCIENCES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: LUPIN  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PFIZER  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 23, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS